• for at sikre passende monitorering af introduktionen af ny ReFacto AF på markedet • for at sikre passende implementering af pharmacovigilance systemet/ risk management planen
• to ensure appropriate monitoring of the introduction of the new Refacto AF on the market • to ensure appropriate implementation of the pharmacovigilance system / risk management plan